A

Amunix

90 employees

Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.

Investor insights

Funding rounds participated in

$20M sweet spot round size

Most of their 1 investments are in rounds between $20M and $20M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical

Date founded

2006

Investments made

U

Undisclosed raised $20M on October 8, 2013

Investors: Aisling Capital, Advent Venture Partners, Sofinnova Ventures, Russia technology fund, New Leaf Venture Partners, Index Ventures and Amunix

Funding rounds raised

Total raised

$117M

from 15 investors over 15 rounds

A

Amunix raised $117M on March 4, 2021

Investors: Omega Funds, Redmile Group, Polaris Partners, Viking Global Investors, Longitude Capital and Frazier Healthcare Partners

A

Amunix raised $73M on March 4, 2020

Investors: Omega Funds, 北京德联运通投资管理有限公司, Venrock, Longitude Capital, Polaris Partners, Redmile Group, Casdin Capital, LLC, Frazier Healthcare Partners and Two River

FAQ